JP2002517244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002517244A5 JP2002517244A5 JP2000553584A JP2000553584A JP2002517244A5 JP 2002517244 A5 JP2002517244 A5 JP 2002517244A5 JP 2000553584 A JP2000553584 A JP 2000553584A JP 2000553584 A JP2000553584 A JP 2000553584A JP 2002517244 A5 JP2002517244 A5 JP 2002517244A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- polypeptide
- seq
- composition
- complement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033319 polynucleotide Proteins 0.000 description 15
- 239000002157 polynucleotide Substances 0.000 description 15
- 102000040430 polynucleotide Human genes 0.000 description 15
- 229920001184 polypeptide Polymers 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 7
- 239000012472 biological sample Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010061309 Neoplasm progression Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000003463 hyperproliferative effect Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000005751 tumor progression Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8887798P | 1998-06-11 | 1998-06-11 | |
| US09/328,475 US6476207B1 (en) | 1998-06-11 | 1999-06-09 | Genes and gene expression products that are differentially regulated in prostate cancer |
| US60/088,877 | 1999-06-09 | ||
| US09/328,475 | 1999-06-09 | ||
| PCT/US1999/013181 WO1999064594A2 (en) | 1998-06-11 | 1999-06-10 | Genes and gene expression products that are differentially regulated in prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002517244A JP2002517244A (ja) | 2002-06-18 |
| JP2002517244A5 true JP2002517244A5 (enExample) | 2006-07-20 |
Family
ID=26779140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000553584A Pending JP2002517244A (ja) | 1998-06-11 | 1999-06-10 | 前立腺癌において示差的に調節される遺伝子および遺伝子発現産物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6476207B1 (enExample) |
| EP (1) | EP1086218A2 (enExample) |
| JP (1) | JP2002517244A (enExample) |
| ES (1) | ES2402095T3 (enExample) |
| WO (1) | WO1999064594A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030215803A1 (en) * | 2000-12-07 | 2003-11-20 | Garcia Pablo Dominguez | Human genes and gene expression products isolated from human prostate |
| US8101349B2 (en) | 1997-12-23 | 2012-01-24 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells and their methods of use II |
| US6861215B1 (en) | 1998-05-21 | 2005-03-01 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging prostate cancer |
| US6156515A (en) * | 1999-02-09 | 2000-12-05 | Urocor, Inc. | Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| CA2373191A1 (en) * | 1999-05-14 | 2000-11-23 | Incyte Genomics, Inc. | Full-length molecules expressed in human tissues |
| US20020168638A1 (en) * | 2000-01-24 | 2002-11-14 | Robert Schlegel | Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
| JP2003527860A (ja) * | 2000-03-23 | 2003-09-24 | イミューソル インコーポレイテッド | Ｂｒｃａ−１制御因子およびその使用方法 |
| WO2001073030A2 (en) * | 2000-03-28 | 2001-10-04 | Diadexus, Inc. | Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| AU2001287269A1 (en) * | 2000-03-28 | 2001-10-08 | Chiron Corporation | Human genes and expression products |
| EP1309679A2 (en) * | 2000-08-16 | 2003-05-14 | Chiron Corporation | Human genes and gene expression products |
| EP1474528A4 (en) * | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS |
| EP1847620A3 (en) * | 2000-10-13 | 2008-10-22 | Cedars-Sinai Medical Center | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| PL362606A1 (en) * | 2000-11-28 | 2004-11-02 | Wyeth | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| JP2004526429A (ja) * | 2000-12-07 | 2004-09-02 | カイロン コーポレイション | ヒト前立腺から単離したヒト遺伝子および遺伝子発現産物 |
| US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| AUPS187002A0 (en) * | 2002-04-22 | 2002-05-30 | Queensland University Of Technology | Condition-specific molecules and uses therefor |
| KR20060073589A (ko) * | 2003-08-07 | 2006-06-28 | 카이론 코포레이션 | 항암 치료법을 위한 표적으로서 트레포일 인자 3(ｔｆｆ3) |
| WO2005078124A2 (de) * | 2004-02-16 | 2005-08-25 | Proteosys Ag | Diagnostische marker für krebs |
| US7657383B2 (en) * | 2004-05-28 | 2010-02-02 | International Business Machines Corporation | Method, system, and apparatus for compactly storing a subject genome |
| US7666595B2 (en) | 2005-02-25 | 2010-02-23 | The Brigham And Women's Hospital, Inc. | Biomarkers for predicting prostate cancer progression |
| EP3640329A1 (en) * | 2018-10-18 | 2020-04-22 | Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) | Gene editing based cancer treatment |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5561041A (en) * | 1993-11-12 | 1996-10-01 | The Johns Hopkins University School Of Medicine | Nucleic acid mutation detection by analysis of sputum |
| US6025127A (en) * | 1994-01-14 | 2000-02-15 | The Johns Hopkins University School Of Medicine | Nucleic acid mutation detection in histologic tissue |
| CA2198702C (en) * | 1994-08-31 | 2010-11-02 | David Sidransky | Detection of hypermutable nucleic acid sequence in tissue |
| US5856094A (en) * | 1995-05-12 | 1999-01-05 | The Johns Hopkins University School Of Medicine | Method of detection of neoplastic cells |
| US5767258A (en) * | 1995-05-12 | 1998-06-16 | The Johns Hopkins University School Of Medicine | Cell cycle regulatory gene |
| US5594402A (en) * | 1995-06-02 | 1997-01-14 | International Power Group, Inc. | High voltage isolating transformer module |
| WO1998004689A1 (en) | 1995-07-31 | 1998-02-05 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| US5861248A (en) * | 1996-03-29 | 1999-01-19 | Urocor, Inc. | Biomarkers for detection of prostate cancer |
| JP2002511734A (ja) * | 1996-11-21 | 2002-04-16 | シーダーズ―サイナイ・メディカル・センター | 下垂体―腫瘍―形質転換遺伝子及び関連生成物 |
-
1999
- 1999-06-09 US US09/328,475 patent/US6476207B1/en not_active Expired - Fee Related
- 1999-06-10 EP EP99927460A patent/EP1086218A2/en not_active Withdrawn
- 1999-06-10 WO PCT/US1999/013181 patent/WO1999064594A2/en not_active Ceased
- 1999-06-10 ES ES04015121T patent/ES2402095T3/es not_active Expired - Lifetime
- 1999-06-10 JP JP2000553584A patent/JP2002517244A/ja active Pending
-
2002
- 2002-07-23 US US10/202,193 patent/US20020192699A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002517244A5 (enExample) | ||
| JP2006500949A5 (enExample) | ||
| JP2004512022A5 (enExample) | ||
| JP2003501038A5 (enExample) | ||
| JP2007506426A5 (enExample) | ||
| JP2002518010A5 (enExample) | ||
| JP2002521055A5 (enExample) | ||
| JP2004512824A5 (enExample) | ||
| JP2005522999A5 (enExample) | ||
| WO1995034650A3 (en) | Mn gene and protein | |
| JP2006518186A5 (enExample) | ||
| JP2004500013A5 (enExample) | ||
| JP2005514923A5 (enExample) | ||
| JP2001521744A5 (enExample) | ||
| JP2005511023A5 (enExample) | ||
| JP2002512005A5 (enExample) | ||
| CA2294472A1 (en) | Torsin, torsin genes, and methods of use | |
| JP2005512558A5 (enExample) | ||
| JP2005507648A5 (enExample) | ||
| JP2006503575A5 (enExample) | ||
| JP2003507029A5 (enExample) | ||
| JP2006501465A5 (enExample) | ||
| JP2002516658A5 (enExample) | ||
| US20080108070A1 (en) | Methods, compositions, and kits for the detection and monitoring of colon cancer | |
| WO2007114954A2 (en) | Methods, compositions, and kits for the detection and monitoring of kidney cancer |